Medical Weight Loss for Methuen, Massachusetts Residents
Methuen, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Methuen through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Methuen Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Methuen, Massachusetts residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Methuen is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Methuen patients at home.
In Methuen, Massachusetts, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Methuen and the Merrimack Valley of Essex County. Whether you are starting your first GLP-1 program or switching from a brand medication, your Methuen treatment plan is built around your health history and goals.
For Methuen residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Methuen is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month · just $7.70/day for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Methuen
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Methuen
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Methuen address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Methuen
Does New Hope Weight Loss treat patients in Methuen?
Yes. Although the clinic is in Costa Mesa, California, we treat Methuen, Massachusetts residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Methuen?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Methuen address in cold-pack packaging.
What do Methuen patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Methuen do you serve?
We serve patients from across Methuen by telehealth, including Methuen and the Merrimack Valley of Essex County.
How does compounded medication compare on cost for Methuen patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Methuen patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Methuen, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.